XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury stock
Noncontrolling interest in consolidated subsidiaries
Total
Beginning balance at Dec. 25, 2021 $ 27,900 $ 1,479 $ 2,394,307 $ (263,127) $ (773,712) $ 26,750 $ 1,413,597
Increase (Decrease) in Shareholders' Equity              
Net earnings     62,311     595 62,906
Other comprehensive income       30,967   1,093 32,060
Cash dividends declared     (11,721)       (11,721)
Stock plan exercises         (2,527)   (2,527)
Stock options exercised   (536)     1,249   713
Stock option expense   716         716
Stock awards   3,592     5,155   8,747
Ending balance at Mar. 26, 2022 27,900 5,251 2,444,897 (232,160) (769,835) 28,438 1,504,491
Beginning balance at Dec. 31, 2022 27,900   2,593,039 (274,909) (765,183) 60,865 1,641,712
Increase (Decrease) in Shareholders' Equity              
Net earnings     74,540     (2,195) 72,345
Other comprehensive income       8,776   293 9,069
Cash dividends declared     (12,634)       (12,634)
Dividends to noncontrolling interests           (662) (662)
Purchase of treasury shares         (111,115)   (111,115)
Stock plan exercises         (14,022)   (14,022)
Stock options exercised   971 (19,317)   23,364   5,018
Stock option expense   855         855
Stock awards   $ (1,826)     9,660   7,834
Ending balance at Apr. 01, 2023 $ 27,900   $ 2,635,628 $ (266,133) $ (857,296) $ 58,301 $ 1,598,400